Research & Development: Page 67
-
PharmaVoice Team/PharmaVoice
UpFront
» Scott Weintraub Honored Scott Weintraub, founding principle of Healthcare Regional Marketing, has been selected for the 2010 Outstanding Leadership Recognition Award by the U.S. Leaders and Entrepreneur’s Association (USLEA). The USLEA Awards Program recognizes highly regarded individuals...
By PharmaVoice Team • March 28, 2011 -
PharmaVoice Team/PharmaVoice
Thought Leaders
Ryan Abbate. President, Pacific Communications, a healthcare communications agency that offers strategic and tactical communications solutions. For more information, visit pacific-com.com. Edward Abrahams, Ph.D. President,The Personalized Medicine Coalition, which brings together the academ...
By PharmaVoice Team • March 7, 2011 -
Explore the Trendline➔
Stock via Getty Images
TrendlineArtificial intelligence & machine learning
After years of excited buzz around the potential of artificial intelligence and machine learning, pharma has begun to realize the true implications and potential value of these technologies.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
Around the World in 3,650 Days
Some experts say globalization will be the big story. As companies expand into new geographies to increase their revenue footprint and meet unmet healthcare needs, they will leverage talent wherever it is located to deliver solutions to markets everywhere. “The current model of serving mature mar...
By PharmaVoice Team • March 7, 2011 -
PharmaVoice Team/PharmaVoice
Business Not As Usual
A decade ago, our experts identified the need for pharmaceutical companies to begin to re-evaluate the business model in light of commercialization hurdles, a looming patent cliff, pipeline constrictions, mergers and acquisitions to name just a few game changers. Now, 10 years later some of these...
By PharmaVoice Team • March 7, 2011 -
PharmaVoice Team/PharmaVoice
Agility: Key to Agency Success in the Future
For anybody involved in healthcare advertising, on the agency as well as the client side, the last decade has been marked by myriad changes and market factors that have impacted all aspects of the business. Client mergers and acquisitions, heightened regulatory scrutiny of messaging, more messagi...
By PharmaVoice Team • March 7, 2011 -
PharmaVoice Team/PharmaVoice
A Decade of Change
During the past decade there have been tremendous advances in science, innovation, technology, communications, and patient engagement. There have also been some tremendous setbacks, including major drug recalls, intensified regulatory oversight, and let’s not forget the infamous “gas-and-go" tac...
By Taren Grom • March 7, 2011 -
PharmaVoice Team/PharmaVoice
Last Word
PV: What are some of the challenges facing pharmaceutical companies that technology can address? Kumar: With shrinking drug pipelines, companies are investing in better collaboration, standardization, and analytical tools to improve R&D productivity as well as their sales and marketing opera...
By PharmaVoice Team • March 3, 2011 -
PharmaVoice Team/PharmaVoice
On the Calendar
March 21-22 BioConference Live: Life Sciences PharmaVOICE is exhibiting at this event. BioConference Live, bioconferencelive.com March 21-23 Digital Marketing & Communications for Canadian Pharma Toronto PharmaVOICE subscribers receive a $200 discount; register using keycode PharmaVOICE Adva...
By PharmaVoice Team • March 3, 2011 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Pharmaceutical companies will see an opportunity to increase their visibility with consumers, influence health outcomes, and reduce healthcare costs while increasing revenue using digital strategies and technology, according to Top Health Industry Issues of 2011, a report published by the Pricewa...
By PharmaVoice Team • March 3, 2011 -
PharmaVoice Team/PharmaVoice
Outlet
According to a new study, media coverage of HIV/AIDS fell more than 70% in developed countries over the last two decades. The Trends in Sustainability Project — a joint project of the University of Leeds, Queen’s University Belfast, the Berlin-based Institute for Futures Studies and Technology As...
By PharmaVoice Team • March 3, 2011 -
PharmaVoice Team/PharmaVoice
UpFront
Patent Cliff By 2016 medicines that generate sales of $133 billion for their manufacturers in the U.S. alone will be exposed to generics, including drugs worth $33.2 billion in 2011 that will lose patent protection in 2012, more than double this year’s figure, according to EvaluatePharma Ltd. P...
By PharmaVoice Team • March 3, 2011 -
PharmaVoice Team/PharmaVoice
Reader Feedback
Who Inspires You? PharmaVOICE Wants to Know! Each year the PharmaVOICE 100 is determined by the collective participation of you, our readers. This is your opportunity to recognize the people who inspire and motivate you and others; who are having the greatest influence on corporate leadership, re...
By PharmaVoice Team • March 3, 2011 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Cheers! Time flies when one is having fun. And the last 10 years have been extremely fun and extremely rewarding. It’s been great getting to know so many of you throughout the life-sciences industry. Back in 2001, the term life-sciences was not common, in fact many questioned us as to what it mea...
By PharmaVoice Team • March 3, 2011 -
PharmaVoice Team/PharmaVoice
SHOWCASE FEATURE: Unclogging the Patient Recruitment Bottleneck
The increased complexity of clinical trial design and the trend toward more targeted patient populations necessitates rethinking the traditional methods of patient recruitment to overcome failure and timeline extensions. Patient recruitment remains to be one of the biggest, and most costly, bott...
By Taren Grom • Jan. 26, 2011 -
PharmaVoice Team/PharmaVoice
M&A: A Short-Term Solution Whose Time May Be Over
2009 was punctuated by the latest and greatest round of major pharmaceutical company mergers, with the big three — Merck and Schering-Plough, Pfizer and Wyeth, and Roche and Genentech — shining a spotlight on M&A practices in the industry. In reality, M&A has always been a growth strategy...
By Robin Robinson • Jan. 26, 2011 -
PharmaVoice Team/PharmaVoice
Developing A True Strategic Partnership
The biopharmaceutical industry is facing intense pressure within research and development to bring new drugs to the market at a time when drug development has become complex and expensive. Blockbuster patent expirations, more complex protocols, increasing R&D costs, patient recruitment issues...
By PharmaVoice Team • Jan. 26, 2011 -
PharmaVoice Team/PharmaVoice
Last Word
PV: What should the goals of a corporate social media program be? Adler: There are many opportunities for companies to engage in social media; generally these fall into three categories. Certainly, chief among the reasons to embark upon a proactive social media program is to enhance awareness amo...
By PharmaVoice Team • Jan. 26, 2011 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharmaceutical POOL Robert DAVIS Dr. Ludwig HANTSON Baxter International Forms Medical Products Business Baxter International has appointed Robert Davis corporate VP and president of its newly created medical products business, which combines the company’s renal and medication delivery businesses...
By PharmaVoice Team • Jan. 26, 2011 -
PharmaVoice Team/PharmaVoice
Tools of the Trade
New Platforms Streamline Scientific Data Sharing Trends: Service providers are harnessing the power of user-generated applications and SaaS to help take scientific search and discovery to the next level. Elsevier’S SCIVERSE APPLICATIONS beta, a new module within the SciVerse content database pl...
By PharmaVoice Team • Jan. 26, 2011 -
PharmaVoice Team/PharmaVoice
What's New
Trend: As the healthcare industry continues to consolidate and rationalize, pharma and biotech companies increasingly need a communications partner that understands how to reach both professional and consumer audiences across traditional and digital channels. New Focus on Digital Healthcare Stra...
By PharmaVoice Team • Jan. 26, 2011 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Trend: With its traditional business model breaking down amid scant financing and lengthy R&D processes, the biotech sector needs to reinvent itself by adopting a more collaborative approach to capitalize on emerging healthcare opportunities. According to the PricewaterhouseCoopers (PwC) rep...
By PharmaVoice Team • Jan. 26, 2011 -
PharmaVoice Team/PharmaVoice
UpFront
Awards… Cephalon wins PRSA Awards CRF Health Wins at Clio Natrel Wins Rx Club Award INDUSTRY at Large Smarty Apps… E-Promotion on the E-Rise Supporting Science Education Lucky 14 Pharma Saves Green by Going Green Disruptive Technology, Disruptive times Top Innovators Podcasts Best Practices for Y...
By PharmaVoice Team • Jan. 26, 2011 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Pharma 3.0: Are you ready? The era of Pharma 3.0 is upon us. According to Ernst & Young (EY), several industry trends, including healthcare reform, health IT, comparative effectiveness, and the rising confidence in consumer power, are driving nontraditional companies into the life-sciences se...
By Taren Grom • Jan. 26, 2011 -
PharmaVoice Team/PharmaVoice
Emerging Market: Ola Brazil
With every passing year, the pharmaceutical industry becomes more global in its outlook and reach. In recognition of our shrinking world, PharmaVOICE is taking you on a journey across the globe. Our first stop is Latin America’s largest market, Brazil. Brazil is familiar territory to the pharma...
By Kim Ribbink • Dec. 27, 2010 -
PharmaVoice Team/PharmaVoice
Last Word
Pharma Forecast Simon King, a pharmaceutical company analyst at Datamonitor, comments on trends expected to impact “big pharma" in 2011. PV: Despite a challenging year for Roche, you say restructuring will help the company maintain a strong fiscal position. What other factors do you think will h...
By PharmaVoice Team • Dec. 27, 2010
Previous
